SILO PHARMA, INC. Foreign Currency Transaction Gain (Loss), before Tax
SILO PHARMA, INC. (SILO) reported Foreign Currency Transaction Gain (Loss), before Tax of -$912 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- SILO PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$912.00.
- SILO PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$2.67K.
- SILO PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was $0.00.
- SILO PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-09-30 was -$2.62K.
- SILO PHARMA, INC. foreign currency transaction gain (loss), before tax for fiscal 2020 was -$2.95K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$912.00 10-Q · filed 2026-08-13 | -$3.59K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$2.67K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $0.00 derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | -$2.62K derived: sum of 2 quarters · filed 2026-04-14 | -$5.55K derived: sum of 3 quarters · filed 2026-04-14 | -$14.24K POS AM · filed 2026-04-14 |
| 2024-09-30 | -$2.62K 10-Q · filed 2025-11-13 | -$5.55K derived: sum of 2 quarters · filed 2025-11-13 | -$14.24K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$2.93K 10-Q · filed 2025-08-13 | -$11.62K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$8.70K 10-Q · filed 2025-05-09 | |||
| 2020-12-31 | -$2.95K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |